Professor of Neurology, Mayo Medical School
Neurology
Dr. Terrence L. Cascino, MD
|
|
Give Review
Terrence Cascino practices Neurology. He studied medicine at Loyola University Chicago Stritch School of Medicine. He received 2 awards: "America's Top Doctors" and "America's Top Doctors for Cancer". Terrence Cascino is a published MD as well. He has 55 publications published. The latest was: Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas. Dr. Terrence L. Cascino accepts Medicare payments and is registered with Medicare.gov.
Publications
- Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.
- Preparing professionals to serve in a reformed health care System.
- Education scholarship.
- Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic Astrocytoma: final report of ...
- Quantitative CT assessment of furosemide- and mannitol-induced changes in Brain water content.
- Radiation-associated atheromatous disease of the cervical carotid Artery: report of seven cases and review of the literature.
- Treatment of patients with Brain tumors.
- Nonconvulsive status epilepticus in a patient with leptomeningeal Cancer.
- Response criteria for phase II studies of supratentorial malignant glioma.
- Neurologic complications of Systemic cancer.
- Brain metastasis in hypernephroma.
- Anaplastic oligodendroGliomas.
- Hemimasticatory spasm: clinical and electrophysiologic observations.
- Complex partial status epilepticus in a patient with leptomeningeal carcinomatosis.
- Bilateral loss of vision in bright light.
- Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG.
- Magnetic resonance imaging in brachial plexopathy of Cancer.
- Outcome after Spinal reirradiation for malignant epidural Spinal cord compression.
- Brain metastases from colon cancer.
- Radiosurgical treatment of recurrent hemangiopericytomas of the meninges: preliminary results.
- Results of computer-assisted stereotactic laser resection of deep-seated intracranial lesions.
- Case-control study of neuroepithelial tumors in Rochester, Minnesota, 1950-1977.
- Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in Cancer patients.
- Intra-arterial BCNU in the treatment of metastatic Brain tumors.
- Brain metastasis from melanoma.
- Evaluation of fludarabine phosphate in patients with recurrent glioma.
- Cerebral Astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy.
- Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors.
- Brain metastases from colorectal carcinoma. The long term survivors.
- Paraneoplastic brachial plexopathy in a patient with Hodgkin's Disease.
- Outcome of peroneal neuropathies in patients with Systemic malignant disease.
- High-grade Astrocytomas: resource use, clinical outcomes, and cost of care.
- Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?
- Intracranial Chordomas: a clinicopathological and prognostic study of 51 cases.
- Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma.
- Magnetic resonance imaging in Cancer-related lumbosacral plexopathy.
- A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic Astrocytoma: a prelimina...
- A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas.
- Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
- Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse Astrocytoma.
- Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.
- Phase II study of amonafide in patients with recurrent glioma.
- Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatm...
- A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
- Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade Gliomas.
- Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma.
- Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary Brain tumors.
- Phase II study of 5-fluorouracil and leucovorin in recurrent primary Brain tumor.
- Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent Astrocytoma.
- Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
- Phase II trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma.
- Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
- Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastom...
- Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients.
Schools
Northwestern University The Feinberg School Of Medicine
Presby Sdt Lukes Hospital
Mayo Grad School Med
Conditions Treated
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Cerebral Artery Thrombosis
- Convulsions
- Dementia
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
Education
-
Memorial Sloan-Kettering Cancer Center -
Mayo School of Graduate Medical Education -
Rush University Medical Center -
Loyola University Chicago Stritch School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1720065568 | |
| NPPES Provider LastName | CASCINO | |
| NPPES Provider FirstName | TERRENCE | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Neurology | |
| Total Claim Count | 27.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720065568 |
| Last Name Of The Provider | CASCINO |
| First Name Of The Provider | TERRENCE |
| View All |
Similar Doctors
|
|
Dr. Jeffrey W. Britton, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patty P. Atkinson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Sorenson, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Terrence D. Lagerlund, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine C. Nickels, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allan J. Dale, MD |
|
|
Dr. Melinda S. Burnett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa C. Lipford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter J. Dyck, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Cong Z. Zhao, MD |